Nuzenio

Prostate Cancer Onclive

Prostate Cancer Onclive entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

SYNC-T Therapy SV-102 Shows Early Promise, Advances to Phase 2 LEGION-100 Trial in Refractory Prostate Cancer - OncLiveOncLive · Mon, 10 Aug 2026 12:11:30 GMTFive Under 5: Top Oncology Videos for the Week of 8/2 - OncLiveOncLive · Sun, 09 Aug 2026 10:23:10 GMTDr Thompson on 5-ARIs for Active Surveillance in Prostate Cancer - OncLiveOncLive · Fri, 07 Aug 2026 20:36:49 GMTExploring the Rationale for 5-Alpha Reductase Inhibitors in Prostate Cancer Prevention and Active Surveillance - OncLiveOncLive · Fri, 07 Aug 2026 19:32:40 GMTDr Morris on the FDA Approval of Lutetium Lu 177 Vipivotide Tetraxetan in PSMA+ mHSPC - OncLiveOncLive · Thu, 06 Aug 2026 16:51:58 GMT

Timeline

Mon, 10 Aug 2026 12:11:30 GMTSYNC-T Therapy SV-102 Shows Early Promise, Advances to Phase 2 LEGION-100 Trial in Refractory Prostate Cancer - OncLive
Sun, 09 Aug 2026 10:23:10 GMTFive Under 5: Top Oncology Videos for the Week of 8/2 - OncLive
Fri, 07 Aug 2026 20:36:49 GMTDr Thompson on 5-ARIs for Active Surveillance in Prostate Cancer - OncLive
Fri, 07 Aug 2026 19:32:40 GMTExploring the Rationale for 5-Alpha Reductase Inhibitors in Prostate Cancer Prevention and Active Surveillance - OncLive
Thu, 06 Aug 2026 16:51:58 GMTDr Morris on the FDA Approval of Lutetium Lu 177 Vipivotide Tetraxetan in PSMA+ mHSPC - OncLive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Prostate Cancer Onclive.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.